These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22847602)

  • 21. Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.
    Sumner SA; Mercado-Crespo MC; Spelke MB; Paulozzi L; Sugerman DE; Hillis SD; Stanley C
    Prehosp Emerg Care; 2016; 20(2):220-5. PubMed ID: 26383533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.
    Walley AY; Xuan Z; Hackman HH; Quinn E; Doe-Simkins M; Sorensen-Alawad A; Ruiz S; Ozonoff A
    BMJ; 2013 Jan; 346():f174. PubMed ID: 23372174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personal social network factors associated with overdose prevention training participation.
    Wagner KD; Iverson E; Wong CF; Bloom JJ; McNeeley M; Davidson PJ; McCarty C; Kral AH; Lankenau SE
    Subst Use Misuse; 2013 Jan; 48(1-2):21-30. PubMed ID: 22988840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme.
    Sherman SG; Gann DS; Tobin KE; Latkin CA; Welsh C; Bielenson P
    Int J Drug Policy; 2009 Mar; 20(2):137-42. PubMed ID: 18502635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal and non-fatal overdose among opiate users in South Wales: A qualitative study of peer responses.
    Holloway K; Hills R; May T
    Int J Drug Policy; 2018 Jun; 56():56-63. PubMed ID: 29605706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social mixing and correlates of injection frequency among opioid use partnerships.
    Rowe C; Santos GM; Raymond HF; Coffin PO
    Int J Drug Policy; 2017 Mar; 41():80-88. PubMed ID: 28113118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What heroin users tell us about overdose.
    Baca CT; Grant KJ
    J Addict Dis; 2007; 26(4):63-8. PubMed ID: 18032233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.
    Green TC; Heimer R; Grau LE
    Addiction; 2008 Jun; 103(6):979-89. PubMed ID: 18422830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Feeling confident and equipped": Evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in New York City.
    Wolfson-Stofko B; Gwadz MV; Elliott L; Bennett AS; Curtis R
    Drug Alcohol Depend; 2018 Nov; 192():362-370. PubMed ID: 30287108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A qualitative study of overdose responses among Chicago IDUs.
    Sherman SG; Gann DS; Scott G; Carlberg S; Bigg D; Heimer R
    Harm Reduct J; 2008 Jan; 5():2. PubMed ID: 18218071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of community opioid overdose prevention and naloxone distribution programs.
    Clark AK; Wilder CM; Winstanley EL
    J Addict Med; 2014; 8(3):153-63. PubMed ID: 24874759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lay responder naloxone access and Good Samaritan law compliance: postcard survey results from 20 Indiana counties.
    Watson DP; Ray B; Robison L; Huynh P; Sightes E; Walker S; Brucker K; Duwve J
    Harm Reduct J; 2018 Apr; 15(1):18. PubMed ID: 29625609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
    Kerensky T; Walley AY
    Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
    Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
    Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths.
    Strang J
    Addiction; 2015 Jul; 110 Suppl 2():27-35. PubMed ID: 26042565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island.
    Zaller ND; Yokell MA; Green TC; Gaggin J; Case P
    Subst Use Misuse; 2013 Jun; 48(8):590-9. PubMed ID: 23750660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low overdose responding self-efficacy among adults who report lifetime opioid use.
    Tormohlen KN; Tobin KE; Davey-Rothwell MA; Latkin C
    Drug Alcohol Depend; 2019 Aug; 201():142-146. PubMed ID: 31212214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use.
    Baltes A; Devo B; Kaiser M; Birstler J; Brown RT
    WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.